Gene Therapy for Gaucher Disease: AAV, Lentivirus, & More
Gaucher disease occurs when people have mutations, or changes, in... Read more
Gaucher Disease and Myeloma: What Patients and Families Should Know
Two thirds of Gaucher patients have some evidence of bone... Read more
Gaucher Disease: How Peer Support and Empowerment Can Help
Rare diseases can affect all aspects of a patient’s life,... Read more
What Is Our Impact? – NGF 2019 Impact Report
In our 2019 Impact Report, we take a look at... Read more
AVROBIO Receives Orphan-Drug Designation from FDA for AVR‑RD‑02
AVROBIO announced that the U.S. Food and Drug Administration (FDA)... Read more
Developing Enzyme Replacement Therapy – An Insider’s Perspective
Enzyme replacement therapy (ERT) was first approved for use by... Read more
[MEDTalks Video] Managing Bone Health
Growth in Gaucher: Managing Bone Health Dr. Heather A. Lau,... Read more
[MEDTalks Video] Does the Key Biomarker of Gaucher Disease Hold the Key to Understanding?
Illuminating Lyso-Gyl 1: Does the Key Biomarker of Gaucher Disease... Read more
Clinical Trials & Gaucher Disease: Phases, Types, & What You Should Know
Medical research has always been important for furthering our understanding... Read more
Repealing the Affordable Care Act
How Repealing the ACA Could Impact the Gaucher Disease... Read more